Totally agree that this process should be going faster precisely because of what you say. I also agree that those with experience in this field know how long “the process” CAN take which is where their comments point towards. I also believe that the product release work arounds for personalized or even just cell based therapies in place now will make access attainable sooner but wide open access may not be for the couple of years mentioned as that timeframe is consistent with what I read elsewhere regarding some regulatory oversight changes needed for multiple jurisdiction standardization. Best wishes.
News 
Market Data 
Discover 
AI
